Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Multicentric, Open-label Study of Induction Treatment With VELCADE and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure

NCT01084837 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT01084837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01084837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Multicentric, Open-label Study of Induction Treatment With VELCADE and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure
Lead sponsor
PETHEMA Foundation
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2013
Enrollment
60 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma